The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published guidance for companies submitting a Manufacturing Authorisation application or variation on...06 January 2017
Advisory Panel on Hospital Outpatient Payment Meeting Dates Set
- Monday, August 27, 2012, 1 p.m. to 5 p.m. EDT
- Tuesday, August 28, 2012, 9 a.m. to 5 p.m. EDT
- Wednesday, August 29, 2012, 9 a.m. to 5 p.m. EDT
The purpose of the Panel is to advise CMS on the clinical integrity of the Ambulatory Payment Classification (APC) groups and their associated weights, and hospital outpatient therapeutic supervision issues. Each year, the second meeting of the Panel is held after CMS has released the hospital outpatient prospective payment system proposed rule for the coming year, with the 2013 proposed rule expected in July of 2012. This meeting offers the opportunity for raising hospital outpatient payment issues to a group that can recommend actions for CMS to take, with such recommendations typically considered by CMS in the hospital outpatient final rule.
On 16 December 2016, the European Medicines Agency (“EMA”), along with the European Biopharmaceutical Enterprises (“EBE”) organised the fifth annual regulatory...03 January 2017
On 8 December 2016, the European Medicines Agency (“EMA”) organised a workshop in collaboration with the European Commission to gather the views and proposals from stakeholders...03 January 2017